Bile acids, the microbiome, immunity, and liver tumors

New England Journal of Medicine

Volumn 379, Issue 9, 2018, Pages 888-890

  Schramm, Christoph ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CXCL16 CHEMOKINE; ANTIINFECTIVE AGENT; CHEMOKINE RECEPTOR CXCR6;

ARTICLE; CARCINOGENESIS; ENDOTHELIUM CELL; GRAM POSITIVE BACTERIUM; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; INTESTINE FLORA; LIVER CELL; LIVER CELL CARCINOMA; LIVER TUMOR; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY; ANIMAL; DISEASE MODEL; DRUG EFFECT; IMMUNOLOGY; LIVER; METABOLISM; MOUSE;

ANIMALS; ANTI-BACTERIAL AGENTS; BILE ACIDS AND SALTS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GASTROINTESTINAL MICROBIOME; HUMANS; LIVER; LIVER NEOPLASMS; MICE; NATURAL KILLER T-CELLS; RECEPTORS, CXCR6;

EID: 85052900643     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcibr1807106     Document Type: Article

References (5)

1. Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L. Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 2012; 12: 239-52.
2. Ma C, Han M, Heinrich B, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science 2018; 360: eaan5931.
3. Shetty S, Lalor PF, Adams DH. Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity. Nat Rev Gastroenterol Hepatol 2018 May 29 (Epub ahead of print).
4. Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 2018; 359: 91-7.
5. Zeevi D, Korem T, Zmora N, et al. Personalized nutrition by prediction of glycemic responses. Cell 2015; 163: 1079-94.